Fortrea - An innovative CRO driving enhanced clinical trial productivity through better speed, efficiency, and predictability
Biopharma sponsors need better productivity and predictability from their clinical trials, so having an innovative CRO partner that delivers enhanced productivity in clinical trials is essential. Accelerated timelines, lower costs, and continuous improvement in the quality of the results are typically the top concerns. Biopharma industry productivity has declined over time for a variety of reasons, with ever-present contributing factors demanding enhanced productivity from clinical trials. Sponsors require responsive, innovative partners that deliver at the speed of change.
Fortrea is the agile CRO that is returning the Biopharma industry to productivity while maximizing value by infusing future industry trends with our experience and innovation. Biopharma sponsors need a CRO partner that makes a real impact on the speed, efficiency and predictability of clinical trials. At Fortrea, we believe – together, exceptional is possible.
Read more on our website
Article: Modern clinical trials- apply a mix of co-innovation and best practices to improve productivity and drive ROI
This paper is the first in a multi-part series that examines the range of options that are available to improve productivity throughout each stage of the clinical trial process. This series will provide recommendations for how to identify, prioritize and implement specific strategies that have the best chance of yielding the most immediate, demonstrable results.
Case Study: Deploying Digital Health Innovations to reduce the high patient burden of a Type 2 diabetes Phase II study
Fortrea was approached to conduct a Phase II study and recruit 225 patients who have chronic kidney disease with Type 2 diabetes mellitus. The trial placed a high burden on patients with daily injections for 6-months and was placebo controlled. This posed challenges for patient recruitment, retention and adherence. Fortrea deployed several digital health innovation techniques to minimize patient burden, resulting in good adherence and low participant drop out.
Case Study: Innovation can be viewed as the application of better solutions that meet existing market needs
A startup medical device manufacturer developed an innovative orthopedic device designed to provide full knee extension following total knee replacement surgery. The technology was simpler and more effective than existing alternatives, but there was a major problem: the manufacturer had no billing code. A Fortrea senior principal advisor assessed the current reimbursement landscape to determine what was needed to obtain the desired coding assignment of the knee aid device.
Whitepaper: Fortrea Site Connections: promoting collaborative partnerships between sites and CROs
Learn how Fortrea leverages our 30+ years of experience as a CRO, establishing Fortrea Site Connections to coordinate our site-focused efforts. Fortrea proactively engages sites, actively listening to their needs and responding with innovative new approaches that enables them to do what sites do best: deliver trials to the patients in their care. Sites represent both the front line and the last mile of a clinical trial, underlining the essential role they play in making clinical trials a reality for the patients in their care. By focusing on removing the roadblocks and challenges faced by sites and patients, more cutting-edge treatments will reach more patients sooner.
Infosheet: Preferred provider strategic relationship for clinical trial solutions
Time and cost efficiency, with access to the right expertise and insight, are paramount to navigating the dynamic development environment and delivering transformative therapies to patients. Forbion and Fortrea have established a strategic collaboration to facilitate easy and accelerated access to Fortrea’s clinical study services for Forbion’s portfolio companies and create desired efficiencies.
